Pass Our Capabilities- Pages Big-2.png

Our partnerships

biosimilar-partnerships.jpg

Pass Our Capabilities Pages Small-2.png

We value strategic partnerships. Like our partnership with Celltrion for the launch of two biosimilars in North America in 2020.

And our exclusive partnership with Alvotech for the commercialization of five biosimilar product candidates in the
United States. Together, we’re working to build value in a number of therapeutic areas.

BackNext

Teva biosimilars Mission: Making Biosimilars accessible to patients who need them

Our mission

Learn how we're making biosimilars more accessible.

Learn more
Teva Capabilities: Finding new ways to unleash value

Our capabilities

See how we’re unleashing value on many fronts.

Learn more
Teva Biosimilar Expertise: Meet the Leaders of Teva

Our expertise

Meet the vanguards leading the way in the new frontier.

Learn more
Teva Biosimilar Products and Partnerships

Our biosimilars

Discover our innovations in the new frontier.

Learn more
Exploring Biosimilars with Teva Biosimilars

Explore biosimilars

Learn why biosimilars are the new frontier.

Learn more